Skip to main content

Oaktree Acquisition Corp. III Life Sciences

For the period ended Mar 31, 2025. Filed May 14, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 14, 2025

OACC$10.70-0.2%Stored close · as of Nov 5, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Table of Contents

Page
Part I. Financial Information
Item 1. Financial Statements
Condensed Balance Sheets as of March 31, 2025 (Unaudited) and December 31, 20241
Condensed Statement of Operations for the three months ended March 31, 2025 (Unaudited)2
Condensed Statement of Changes in Shareholders’ Deficit for the three months ended March 31, 2025(Unaudited)3
Condensed Statement of Cash Flows for the three months ended March 31, 2025 (Unaudited)4
Notes to Condensed Financial Statements (Unaudited)5
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations16
Item 3. Quantitative and Qualitative Disclosures About Market Risk18
Item 4. Controls and Procedures18
Part II. Other Information
Item 1. Legal Proceedings18
Item 1A. Risk Factors18
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds18
Item 3. Defaults Upon Senior Securities19
Item 4. Mine Safety Disclosures19
Item 5. Other Information19
Item 6. Exhibits19
Part III. Signatures20

PART I - FINANCIAL INFORMATION

Item 1. Interim Financial Statements.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.